SMAD7 and esophageal squamous cell carcinoma: Plasma levels of circ-SMAD7 were significantly lower in patients with ESCC than that in normal controls and correlated with the TNM stage and lymphatic metastasis, serving as a novel diagnostic biomarker for ESCC [73].